Research
Study: Pickleball-related eye injuries on the rise
Pipeline
MeiraGTx acquires J&J's XLRP investigational therapy
Deal includes all interests in botaretigene sparoparvovec (bota-vec); company plans to immediately file for global regulatory approval.
Research
Popular GLP-1RA may increase risk for ION and vision loss
Study findings suggest a potential dose- and formulation-dependent association between semaglutide and ischemic optic neuropathy
Pipeline
Belite Bio begins rolling NDA submission of oral tinlarebant for Stargardt
Full submission planned for Q2 2026, once-daily tablet has potential to become the first-ever treatment approved for this patient base.
Events
Nutritional supplementation is redefining eye health management
Highlights from Bausch + Lomb’s first-ever consumer summit.
Research
Maternal diabetes exposure increases severe ROP risk
In-utero exposure to maternal diabetes may raise the odds, even in infants who appear lower risk by traditional measures.
Pipeline
Merck kicks off phase 2b/3 trial on tri-specific antibody for wet AMD
Merck initiates next phase of clinical testing in ophthalmology with two candidates targeting nAMD and DME.
Events
Retina Summit 2026: OD updates for AMD management and imaging
Key takeaways from AAO’s one-day meeting explore retina care’s shift from referral-based to decision-making at the OD level.
Legal
Tennessee passes OD bill authorizing in-office laser procedures
Senate Bill 2076 permits licensed optometrists to perform three in-office laser procedures as well as the administration of local anesthesia.
Pipeline
Ocular Therapeutix releases additional phase 3 AXPAXLI data for wet AMD
Data from SOL-1 phase 3 data will become the basis of a planned NDA submission in near future.
Research
Does smoking age your eyes?
Mouse model study finds cigarette smoke may cause changes in eye cells similar to aging damage, with younger and older cells differing in protection.
Pipeline
FDA accepts Outlook Therapeutics' request over rejected wet AMD BLA
Company challenges decision on failed third submission package of ONS-5010 / LYTENAVA (bevacizumab-vikg), with a decision expected in May.
Research
Vitamin D deficiency leads to increased dry eye risk
Study findings suggest patients with low Vitamin D levels may face a higher likelihood of developing DED.
Events
ASCRS 2026 highlights key trends in surgical ecosystem
Annual meeting of cataract and refractive surgeons kicks off in the nation’s capital with focus on developments in surgical devices and IOLs.
Products
CMS assigns Glaukos’ Epioxa a permanent J-code
Corneal CXL therapy was approved in October 2025 as the first topical drug not requiring removal of the corneal epithelium for keratoconus treatment.
Events
B+L Consumer Summit highlights OTC integration as key to managing ocular surface health
Clinicians emphasize over-the-counter options as a first-line treatment for ocular surface disease during Bausch + Lomb’s one-day consumer summit.
Products
Iantrek introduces AlloSpan Canal to its bio-interventional platform
Tech combines nitinol-guided canaloplasty with allogeneic biological scaffolding to restore and maintain Schlemm’s canal—without leaving synthetic hardware in the eye.
Products
ForSight Robotics performs FIH robot-based cataract surgery
FIH procedure marks the start of clinical trial testing of the JASPER Platform to secure clinical validation and regulatory submissions.
Products
Johnson & Johnson launches expanded parameters for ACUVUE VITA contact lenses
Monthly lens now offers ‘around the clock’ coverage across the full power range (-9.00 to +6.00) for astigmatic patients.
Products